Alector, Inc. (ALEC) News
Filter ALEC News Items
ALEC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ALEC News Highlights
- 500 - Internal server error
- Over the past 15 days, the trend for ALEC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about ALEC are CNTG and DE.
Latest ALEC News From Around the Web
Below are the latest news stories about Alector Inc that investors may wish to consider to help them evaluate ALEC as an investment opportunity.
Centogene, Alector initiate EFRONT study in frontotemporal dementiaCentogene N.V. (CNTG) announces a new observational study to understand the prevalence of genetic mutations in patients with frontotemporal dementia ((FTD)).The observational EFRONT Study is being conducted with Alector (ALEC) under a commercial agreement.Financial details of the deal are not disclosed. The study aims to enroll and genetically test more... |
Alector: Pioneering Approach In CNS DiseasesPhoto by libre de droit/iStock via Getty Images Alector (ALEC) harnesses genetic technology to target the immune system based on the hypothesis that the immune system causes neurodegeneration. Understandably, that's a lot of science thrown into one sentence - and one company. But Alector is a pioneer in immuno-neurology, and... |